3,4-di-substituted cyclobutene-1, 2 -diones as CXC chemokine receptor antagonists
A Standard patent application filed on 01 February 2002 credited to Taveras, Arthur, G.
;
Kaiser, Bernd
;
Aki, Cynthia, J.,
;
Li, Ge
;
Merritt, J., Robert
;
Chao, Jianping
;
Bond, Richard, W.
;
Baldwin, John, J.
;
Pachter, Jonathan
;
Nelson, Kingsley, H., Jr.
;
Rokosz, Laura, L.
Details
Application number :
2002303084
Application type :
Standard
Application status :
CEASED
Under opposition :
No
Proceeding type :
Invention title :
3,4-di-substituted cyclobutene-1, 2 -diones as CXC chemokine receptor antagonists
Inventor :
Taveras, Arthur, G.
;
Kaiser, Bernd
;
Aki, Cynthia, J.,
;
Li, Ge
;
Merritt, J., Robert
;
Chao, Jianping
;
Bond, Richard, W.
;
Baldwin, John, J.
;
Pachter, Jonathan
;
Nelson, Kingsley, H., Jr.
;
Rokosz, Laura, L.
Agent name :
Griffith Hack
Address for service :
Level 29, Northpoint 100 Miller Street North Sydney NSW 2060 Australia
Filing date :
01 February 2002
Associated companies :
Applicant name :
Schering Corporation
Applicant address :
Patent Department - K-6-1 1990 2000 Galloping Hill Road Kenilworth NJ 07033-0530 United States of America
Old name :
Pharmacopeia, Inc.
;
Pharmacopiea Drug Discovery, Inc.